Une entreprise certifiée ISO 9001, 14001, 45001 sales@bldpharm.com
Monnaie :
Langue : Français |
Lieu :
Lieu
  • Americas
    • Europe
      • Asia Pacific
        • Africa & Middle East
          |
          Accueil/ Inhibitors/Agonists/ Cytoskeleton/ Integrin/ 2-((3R,11S,17S,20S,25aS)-20-((1H-Indol-3-yl)methyl)-3-carbamoyl-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl)acetic acid

          2-((3R,11S,17S,20S,25aS)-20-((1H-Indol-3-yl)methyl)-3-carbamoyl-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl)acetic acid

          CAS NO.: 188627-80-7  
            Taille Prix Sale Price Remise Stock-CN Stock-US Stock-IND Stock-EU Quantité
            How to Order

            The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

            How to Order

            CONTRÔLE DE QUALITÉ Batch NO.:

            881997-86-0
            BD00796130 881997-86-0 Free-salt
            1248559-53-6
            BD01141747 1248559-53-6 Free-salt

            INFORMATION PRODUIT

            Nom du produit : 2-((3R,11S,17S,20S,25aS)-20-((1H-Indol-3-yl)methyl)-3-carbamoyl-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl)acetic acid
            CAS NO. : 188627-80-7 Masse moléculaire : 831.96
            MDL NO. : MFCD05662245 Pureté/Spécification :
            Formule moléculaire : C35H49N11O9S2 Stockage : Sealed in dry,Store in freezer, under -20°C
            Point d'ébullition : No data available
            GHS Pictogram :
            Signal Word : Warning Precautionary Statements : P260-P314-P501
            UN# : - Class : -
            Hazard Statements : H373 Packing Group : -

            PRODUITS CONNEXES

            RECORDS HISTORIQUES